The present invention relates to novel compounds that can be employed in the treatment of a group of disorders and abnormalities associated with amyloid protein, such as Alzheimer's disease, and of diseases or conditions associated with amyloid-like proteins. The compounds of the present invention can also be used in the treatment of ocular diseases associated with pathological abnormalities/changes in the tissues of the visual system. The present invention further relates to pharmaceutical compositions comprising these compounds and to the use of these compounds for the preparation of medicaments for treating or preventing diseases or conditions associated with amyloid and/or amyloid-like proteins. A method of treating or preventing diseases or conditions associated with amyloid and/or amyloid-like proteins is also disclosed.本發明係關於可用於治療與類澱粉蛋白質相關之一組病症及異常(諸如阿茲海默氏病(Alzheimer's disease))及與類澱粉樣蛋白質相關之疾病或病況的新穎化合物。本發明之化合物亦可用於治療與視覺系統組織之病理異常/改變相關的眼部疾病。本發明另外係關於包含此等化合物之醫藥組合物，及此等化合物用於製備供治療或預防與類澱粉或類澱粉樣蛋白質相關之疾病或病況之藥物的用途。本發明亦揭示一種治療或預防與類澱粉或類澱粉樣蛋白質相關之疾病或病況的方法。
